Azadual is an antineoplastic agent that works as a hypomethylating agent. It is primarily used in the treatment of certain types of myelodysplastic syndromes (MDS), a group of bone marrow disorders. Azadual helps restore normal gene function, promoting healthy blood cell production and inhibiting the growth of abnormal cells in the bone marrow.
Paclitaxel Protein Bound Particles for Injectable Suspension (Albumin Bound) (Lyophilized):
Medication Type: Paclitaxel protein-bound particles are administered via injection.
Purpose: This formulation is used to treat various cancers, including breast, lung, and pancreatic cancer.
Composition: It consists of paclitaxel, a chemotherapy medication, bound to albumin, a protein found in blood.
Mechanism of Action: Paclitaxel disrupts the function of cancer cells by inhibiting their ability to divide and grow, while the albumin helps to deliver the medication to the tumor site.
Dosage: The dosage and frequency of administration are determined by a healthcare provider based on factors such as the type and stage of cancer, as well as the patient's overall health.
Administration: Administered intravenously after reconstitution with a compatible diluent.
Side Effects: Common side effects may include hair loss, nausea, vomiting, fatigue, and decreased blood cell counts.
Precautions: Patients should be monitored closely for signs of allergic reactions and bone marrow suppression during treatment.
Interactions: Paclitaxel may interact with other medications, so it's important to inform the healthcare provider about all medications being taken.
